Category Archives: Uncategorized

FDA Gadolinium Warning 5/23/07

n May 2007, the FDA requested that the manufacturers of the five gadolinium based contrast agents used in MRIs include a boxed warning – the FDA’s strongest possible safety warning – on product labels highlighting the risk they posed to …

Read More

FDA Gadolinium Warning 12/22/06

In December of 2006, the FDA issued its second public health advisory regarding gadolinium based contrast dyes. At that time, the FDA said it had received 90 reports of patients with moderate to end-stage kidney disease who developed NSF after …

Read More

FDA Gadolinium Warning 6/08/06

In June 2006, the Food & Drug Administration (FDA) issued what would be the first of three warnings on gadolinium contrast dyes. Following the publication of the Dutch NSF study in 2006, the FDA issued an alert to healthcare providers …

Read More

Gadolinium MRA Contrast Side Effect Injuries

Gadolinium MRA contrast dye is used in Magnetic Resonance Imaging (MRA) so that diagnosticians can more easily differentiate between normal and abnormal tissue. Unfortunately, Gadolinium MRA contrast dye has been linked to a serious condition called Nephrogenic Systemic Fibrosis (NSF) …

Read More

Gadolinium Linked to Nephrogenic Systemic Fibrosis (NSF) and Nephrogenic Fibrosing Dermopathy (NFD)

Since 1997, medical science has been trying to solve the mystery of NSF/NSD. But until recently, little was known about the causes of NSF/NSD and even less about its treatment. However, in 2006 research into NSF/NSD finally yielded some results. …

Read More

Legal Assistance form NSF and NFD Sufferers Who Had an MRA with Gadolinium Contrast Dye

If you or a loved one believes you developed NSF/NSD from a gadolinium based contrast agent, you have valuable legal rights. Please fill out the form at the left for a free case evaluation or call 1-800-LAW-INFO (1-800-529-4636).

Read More